Copyright
©The Author(s) 2015.
World J Gastroenterol. Jan 7, 2015; 21(1): 254-261
Published online Jan 7, 2015. doi: 10.3748/wjg.v21.i1.254
Published online Jan 7, 2015. doi: 10.3748/wjg.v21.i1.254
Figure 1 Clinical course of 29 patients up to 5 years after GI-CyA therapy.
Patients with a CAI score reduction of ≥ 5 were considered “responders”. The term “no colectomy” includes all patients who were not treated surgically for up to 5 years. CAI: Clinical activity index.
Figure 2 Kaplan-Meier analyses of avoidance of colectomy versus time for responding patients with or without azathioprine treatment (overall, n = 15, with azathioprine, n = 8, and without azathioprine, n = 7, respectively).
P = 0.006 vs no AZA treatment by the log-rank test. AZA: Azathioprine.
- Citation: Miyake N, Ando T, Ishiguro K, Maeda O, Watanabe O, Hirayama Y, Maeda K, Morise K, Matsushita M, Furukawa K, Funasaka K, Nakamura M, Miyahara R, Ohmiya N, Goto H. Azathioprine is essential following cyclosporine for patients with steroid-refractory ulcerative colitis. World J Gastroenterol 2015; 21(1): 254-261
- URL: https://www.wjgnet.com/1007-9327/full/v21/i1/254.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i1.254